glp 1 patient education Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Currently the most serious vision risk from GLP-1 usage is NAION, which can cause total blindness

J Biol Chem

2016;22 (Suppl 3):1203

In individuals without established CVD but with multiple cardiovascular risk factors (such as age 55 years, obesity, hypertension, smoking, dyslipidaemia or albuminuria), a GLP-1 RA with proven benefit could be used to reduce MACE, or an SGLT2i with proven benefit could be used to reduce MACE and HF and improve kidney outcomes

It tells you that the codes are not for patients who have addictions to drugs and not for use of medications for detoxification or maintenance programs to prevent withdrawal symptoms (emphasis added)

GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity